SEC Form 4 · accession 0001013606-17-000168
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vaseem Mahboob
Officer — Chief Financial Officer
Period of report
Nov 8, 2017
Accepted (ET)
Nov 8, 2017 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Nov 8, 2017 | A | 25,000 | $0.00 | A | 149,444 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Fifty percent of the restricted stock units shall vest eighteen months after date of grant, and the remaining balance will vest 36 months after the date of grant, in each case subject to continued service on the applicable vesting date.
Remarks
Total shares owned includes 3,258 shares purchased through the Company's Employee Stock Purchase Plan on October 31, 2017 and have not previously been disclosed due to immateriality.